2cureX is concentrating its operational activities towards defined core
competences of the ChemoCellomics® platform whereas supplementary
drug discovery competences are added through strategic partnerships.
2cureX is open to discuss partnerships with
•
pharmaceutical
and biotechnological companies who seek access to 2cureX’s
lead compounds
•
hospitals and academic groups who possess
unique pathophysiological knowledge and expertise in rare oncological
conditions
•
dynamic research groups (including young
investigators)
with originals ideas for application of the ChemoCellomics®
technolog
